Driehaus Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$86.9M	Sell	1,043,583 -25,655	-2%	-$2.03M	0.64%	39
2025 Q4	$83.2M	Buy	1,069,238 +130,144	+14%	+$8.79M	0.57%	49
2025 Q3	$53.2M	Buy	939,094 +5,204	+0.6%	+$235K	0.38%	84
2025 Q2	$40.8M	Sell	933,890 -234,901	-20%	-$8.09M	0.33%	103
2025 Q1	$32M	Sell	1,168,791 -221,581	-16%	-$8.08M	0.31%	105
2024 Q4	$55.9M	Buy	1,390,372 +61,669	+5%	+$2.79M	0.46%	74
2024 Q3	$62.9M	Buy	1,328,703 +1,105,290	+495%	+$48.8M	0.54%	53
2024 Q2	$6.67M	Buy	+223,413	New	+$7.74M	0.06%	246
2022 Q2	–	Sell	-199,244	Closed	-$8.43M	–	403
2022 Q1	$8.43M	Sell	199,244 -440,238	-69%	-$18.6M	0.1%	254
2021 Q4	$40.6M	Buy	639,482 +56,290	+10%	+$3.28M	0.41%	75
2021 Q3	$34.3M	Buy	583,192 +551,611	+1,747%	+$32M	0.41%	73
2021 Q2	$1.53M	Buy	+31,581	New	+$1.37M	0.02%	324